Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TuHURA Biosciences Inc | James A. Bianco | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 3,414,891 | 3,414,891 | - | - | Options (Right to Buy) | |
| QuantumScape Corp (Class A) | Dipender Saluja | Director | Sale of securities on an exchange or to another person at price $ 11.01 per share. | 12 Dec 2025 | 2,613,121 | 9,892,934 | - | 11.0 | 28,770,462 | Class A Common Stock |
| TuHURA Biosciences Inc | Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 1,531,367 | 1,531,367 | - | - | Options (Right to Buy) | |
| Lumexa Imaging Holdings Inc | Julie Szeker | Chief Legal Officer & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 1,250,000 | 0 | - | - | Incentive Units of Holdings LLC | |
| Relmada Therapeutics Inc | Sergio Traversa | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 1,198,000 | 1,198,000 | - | - | Stock Appreciation Rights | |
| DocGo Inc | Lee Bienstock | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 1,113,495 | 3,050,412 | - | 0 | Common Stock | |
| Navitas Semiconductor Corp | Dipender Saluja | Director | Sale of securities on an exchange or to another person at price $ 8.10 per share. | 12 Dec 2025 | 873,488 | 4,755,536 | - | 8.1 | 7,075,253 | Class A Common Stock |
| Artiva Biotherapeutics Inc | Fred Aslan | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 869,136 | 1,213,135 | - | 0 | Common Stock | |
| Relmada Therapeutics Inc | Maged Shenouda | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 828,000 | 828,000 | - | - | Stock Appreciation Rights | |
| Relmada Therapeutics Inc | Paul Kelly | Director, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 828,000 | 828,000 | - | - | Stock Appreciation Rights | |
| Relmada Therapeutics Inc | Charles S. Ence | CA and CO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 828,000 | 828,000 | - | - | Stock Appreciation Rights | |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.33 per share. | 12 Dec 2025 | 734,511 | 734,511 (0%) | 0% | 50.3 | 36,967,939 | Common Stock |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 734,511 | 1,250,000 | - | - | Option (Right to Buy) | |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 66.80 per share. | 12 Dec 2025 | 732,186 | 2,325 (0%) | 0% | 66.8 | 48,910,025 | Common Stock |
| QuantumScape Corp (Class A) | Dipender Saluja | Director | Sale of securities on an exchange or to another person at price $ 11.94 per share. | 12 Dec 2025 | 684,524 | 12,506,055 | - | 11.9 | 8,173,217 | Class A Common Stock |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 12 Dec 2025 | 590,909 | 75,544,394 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 590,909 | 254,000 | - | 0 | Class A Common Stock | |
| Samsara Inc (Class A) | Sanjit Biswas | Director, CHIEF EXECUTVE OFFICER, Ten Percent Owner | 12 Dec 2025 | 590,909 | 844,909 | - | 0 | Class A Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 12 Dec 2025 | 590,909 | 73,604,341 | - | - | Class B Common Stock | ||
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 590,909 | 274,000 | - | 0 | Class A Common Stock | |
| Samsara Inc (Class A) | John Bicket | Director, SEE REMARKS, Ten Percent Owner | 12 Dec 2025 | 590,909 | 864,909 | - | 0 | Class A Common Stock | ||
| PharmaCyte Biotech Inc | Joshua Nathaniel Silverman | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 575,000 | 575,000 | - | 0 | Common Stock | |
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | 12 Dec 2025 | 506,000 | 845,367 | - | - | Class A Common Stock | ||
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | 12 Dec 2025 | 506,000 | 14,482,500 | - | - | Class B Common Stock | ||
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 506,000 | 14,988,500 | - | - | Class B Common Stock | |
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 506,000 | 1,219,153 | - | - | Stock Option (Right to Buy) | |
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 30.04 per share. | 12 Dec 2025 | 506,000 | 339,367 | - | 30.0 | 15,200,240 | Class A Common Stock |
| Marqeta Inc (Class A) | Jason Gardner | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 502,000 | 14,422,822 | - | 0 | Class A Common Stock | |
| Clear Secure Inc (Class A) | Caryn Seidman Becker | Director, Chief Executive Officer, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 500,000 | 19,130,246 | - | - | Non-voting common units of Alclear Holdings, LLC | |
| Clear Secure Inc (Class A) | Caryn Seidman Becker | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 500,000 | 714,487 | - | - | Class A Common Stock | |
| Clear Secure Inc (Class A) | Caryn Seidman Becker | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 500,000 | 351,787 | - | - | Class B Common Stock | |
| Clear Secure Inc (Class A) | Caryn Seidman Becker | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 500,000 | 851,787 | - | - | Class B Common Stock | |
| Clear Secure Inc (Class A) | Caryn Seidman Becker | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 500,000 | 19,130,246 | - | - | Class D Common Stock | |
| Vera Bradley Inc | Ian Martin Bickley | Director | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 12 Dec 2025 | 461,538 | 788,629 (2%) | 1% | 1.9 | 899,999 | Common Shares |
| DocGo Inc | Norman Rosenberg | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 429,405 | 1,289,345 | - | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 400,000 | 1,045,168 (0%) | 0% | 0 | Common Stock | |
| Olaplex Holdings Inc | Amanda Baldwin | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.19 per share. | 12 Dec 2025 | 398,560 | 5,735,198 | - | 1.2 | 474,286 | Common Stock |
| Merus N.V | Sven Ante Lundberg | Director, President, CEO & PEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 380,000 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Gregory D. Perry | Chief Financial Officer & PFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 372,924 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Sven Ante Lundberg | Director, President, CEO & PEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 360,000 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Sven Ante Lundberg | Director, President, CEO & PEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 351,628 | 0 | - | - | Share Option (right to buy) | |
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 12 Dec 2025 | 348,000 | 866,133 (1%) | 0% | 0 | Class A Common Stock | ||
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | 12 Dec 2025 | 348,000 | 7,974,420 | - | - | Class B Common Stock | ||
| Datadog Inc (Class A) | Olivier Pomel | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 348,000 | 518,133 (0%) | 0% | 0 | Class A Common Stock | |
| DocGo Inc | Stephen Sugrue | Chief Compliance Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 321,055 | 672,570 | - | 0 | Common Stock | |
| Artiva Biotherapeutics Inc | Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 319,331 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Navitas Semiconductor Corp | Dipender Saluja | Director | Sale of securities on an exchange or to another person at price $ 8.65 per share. | 12 Dec 2025 | 315,396 | 5,629,024 | - | 8.6 | 2,728,175 | Class A Common Stock |
| Merus N.V | Sven Ante Lundberg | Director, President, CEO & PEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 312,620 | 0 | - | - | Share Option (right to buy) | |
| News Corp (Class A) | Keith Rupert Murdoch | Chairman Emeritus | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 302,000 | 707,446 (0%) | 0% | 0 | Class B Common Stock | |
| Merus N.V | Sven Ante Lundberg | Director, President, CEO & PEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 300,000 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Sven Ante Lundberg | Director, President, CEO & PEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 295,000 | 0 | - | - | Share Option (right to buy) | |
| SEI Investments Co. | Ryan P. Hicke | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 288,333 | 288,333 | - | - | Option to Purchase Common Stock | |
| Clear Secure Inc (Class A) | Caryn Seidman Becker | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 40.53 per share. | 12 Dec 2025 | 283,263 | 216,737 | - | 40.5 | 11,480,649 | Class A Common Stock |
| Janus Intl Grp Inc (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 272,797 | 213,239 | - | 0 | Common Stock | |
| Janus Intl Grp Inc (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 272,797 | 834,667 | - | 0 | Common Stock | |
| Janus Intl Grp Inc (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 272,797 | 213,239 | - | 0 | Common Stock | |
| Janus Intl Grp Inc (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 272,797 | 752,460 | - | 0 | Common Stock | |
| Vera Bradley Inc | Melinda Paraie | Chief Branding Officer | Grant, award, or other acquisition of securities at price $ 1.95 per share. | 12 Dec 2025 | 269,231 | 269,231 (0%) | 0% | 1.9 | 525,000 | Common Shares |
| PharmaCyte Biotech Inc | Joshua Nathaniel Silverman | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.02 per share. | 12 Dec 2025 | 258,750 | 316,250 | - | 1.0 | 263,925 | Common Stock |
| Artiva Biotherapeutics Inc | Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 257,319 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Vera Bradley Inc | Andrew M. Meslow | Director | Purchase of securities on an exchange or from another person at price $ 1.98 per share. | 12 Dec 2025 | 250,000 | 550,000 (1%) | 0% | 2.0 | 493,750 | Common Shares |
| Angel Studios Inc Ordinary | Neal S. Harmon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 245,916 | 245,916 | - | - | Restricted Stock Units | |
| Hain Celestial Grp Inc | Lee A. Boyce | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 244,445 | 244,445 | - | - | Restricted Share Units | |
| Camping World Holdings Inc (Class A) | Marcus A. Lemonis | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.00 per share. | 12 Dec 2025 | 242,943 | 1,401,016 (3%) | 0% | 10 | 2,429,430 | Class A Common Stock |
| Precigen Inc | Jeffrey B. Kindler | Director | Sale of securities on an exchange or to another person at price $ 3.63 per share. | 12 Dec 2025 | 235,467 | 110,603 (0%) | 0% | 3.6 | 855,899 | Common Stock |
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | 12 Dec 2025 | 232,500 | 14,250,000 | - | - | Class B Common Stock | ||
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 30.10 per share. | 12 Dec 2025 | 232,500 | 339,367 | - | 30.1 | 6,998,250 | Class A Common Stock |
| Confluent Inc (Class A) | Edward Jay Kreps | Director, CHIEF EXECUTIVE OFFICER | 12 Dec 2025 | 232,500 | 571,867 | - | - | Class A Common Stock | ||
| Camping World Holdings Inc (Class A) | Marcus A. Lemonis | Director, CHIEF EXECUTIVE OFFICER, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 217,391 | 1,643,959 (4%) | 0% | 0 | Class A Common Stock | |
| Clear Secure Inc (Class A) | Caryn Seidman Becker | Director, Chief Executive Officer, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 41.31 per share. | 12 Dec 2025 | 214,487 | 2,250 | - | 41.3 | 8,860,458 | Class A Common Stock |
| DocGo Inc | Lee Bienstock | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.91 per share. | 12 Dec 2025 | 214,131 | 2,836,281 | - | 0.9 | 194,859 | Common Stock |
| Corcept Therapeutics Inc | James N. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2025 | 200,000 | 200,000 (0%) | 0% | 0 | Common Stock | |
| Corcept Therapeutics Inc | James N. Wilson | Director | Other type of transaction at price $ 0.00 per share. | 12 Dec 2025 | 200,000 | 200,000 (0%) | 0% | 0 | Common Stock | |
| Hycroft Mining Holding Corp (Class A) | Eric Steven Sprott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.03 per share. | 12 Dec 2025 | 200,000 | 30,386,352 | - | 13.0 | 2,606,000 | Class A common stock |
| Hycroft Mining Holding Corp (Class A) | Eric Steven Sprott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.02 per share. | 12 Dec 2025 | 200,000 | 30,186,352 | - | 13.0 | 2,604,000 | Class A common stock |
| OppFi Inc (Class A) | Theodore Schwartz | Director, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 186,737 | 12,907 | - | 0 | Class A Common Stock | |
| Merus N.V | Fabian Zohren | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 183,943 | 0 | - | - | Share Option (right to buy) | |
| Nerdy Inc (Class A) | Charles Cohn | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.38 per share. | 12 Dec 2025 | 180,353 | 32,495,856 | - | 1.4 | 248,887 | Class A Common Stock |
| Arrowhead Pharma Inc | Christopher Anzalone | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 180,000 | 4,101,255 (4%) | 0% | 0 | Common Stock | |
| Harrow Health Inc | Mark L. Baum | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. | 12 Dec 2025 | 180,000 | 3,066,124 (12%) | 0% | 4.0 | 711,000 | Common Stock |
| Harrow Health Inc | Mark L. Baum | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 180,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Navitas Semiconductor Corp | Ranbir Singh | Director | Sale of securities on an exchange or to another person at price $ 8.68 per share. | 12 Dec 2025 | 179,354 | 389,096 | - | 8.7 | 1,556,829 | Class A Common Stock |
| Arch Capital | John M. Pasquesi | Director, CHAIR | Sale of securities on an exchange or to another person at price $ 93.91 per share. | 12 Dec 2025 | 175,000 | 351,356 (0%) | 0% | 93.9 | 16,434,145 | Common Shares, $.0011 par value per share |
| Shoe Carnival Inc | J. Wayne Weaver | Director, Chairman of the Board, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 166,666 | 4,499,846 (31%) | 1% | 0 | COMMON STOCK | |
| Shoe Carnival Inc | J. Wayne Weaver | Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 166,666 | 4,499,846 (31%) | 1% | 0 | COMMON STOCK | |
| Relmada Therapeutics Inc | Charles J. Casamento | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 164,000 | 164,000 | - | - | Stock Appreciation Rights | |
| Relmada Therapeutics Inc | John Glasspool | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 164,000 | 164,000 | - | - | Stock Appreciation Rights | |
| Relmada Therapeutics Inc | Fabiana Fedeli | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 164,000 | 164,000 | - | - | Stock Appreciation Rights | |
| G-III Apparel Grp Ltd | Jeffrey Goldfarb | Director, Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 159,184 | 746,316 (1%) | 0% | 0 | Common Stock, Par Value $.01 Per Share | |
| Anywhere Real Estate Inc | Ryan M. Schneider | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 157,234 | 2,516,052 (2%) | 0% | 14.6 | 2,294,044 | Common Stock, $0.01 par value |
| Hain Celestial Grp Inc | Kristy M. Meringolo | Ch Legal & Corp Affairs Offcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 155,556 | 155,556 | - | - | Restricted Share Units | |
| Hain Celestial Grp Inc | Wolfgang Goldenitsch | President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 155,556 | 155,556 | - | - | Restricted Share Units | |
| DocGo Inc | Michael J. Burdiek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 150,000 | 791,560 | - | 0 | Common Stock | |
| DocGo Inc | James M. Travers | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 150,000 | 240,999 | - | 0 | Common Stock | |
| DocGo Inc | Ira Smedra | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 150,000 | 240,999 | - | 0 | Common Stock | |
| Gogo Inc | Oakleigh Thorne | Director, Executive Chair, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.35 per share. | 12 Dec 2025 | 150,000 | 954,098 (1%) | 0% | 5.4 | 802,500 | Common Stock |
| Traws Pharma Inc | Iain D. Dukes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 147,771 | 147,771 | - | - | Stock Option (right to purchase) | |
| ImmunityBio Inc | Bruce J. Wendel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 146,020 | 146,020 | - | - | Stock Option (right to buy) | |
| Perimeter Soln SA | Noriko Yokozuka | General Counsel | Sale of securities on an exchange or to another person at price $ 28.44 per share. | 12 Dec 2025 | 137,500 | 47,157 | - | 28.4 | 3,910,500 | Common Stock |
| Monster Beverage | Rodney C. Sacks | Director | Sale of securities on an exchange or to another person at price $ 73.58 per share. | 12 Dec 2025 | 137,204 | 286,228 (0%) | 0% | 73.6 | 10,095,470 | Common Stock |
| Hyliion Holdings Corporation | Thomas Healy | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 1.94 per share. | 12 Dec 2025 | 134,963 | 35,102,148 | - | 1.9 | 261,828 | Common Stock |
| Angel Studios Inc Ordinary | Neal S. Harmon | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 129,176 | 129,176 | - | - | Performance Stock Units | |
| Merus N.V | Peter B. Silverman | COO & GC | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 125,000 | 0 | - | - | Share Option (right to buy) | |
| Perimeter Soln SA | Noriko Yokozuka | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 120,000 | 240,000 | - | - | Stock Option (right to buy) | |
| Perimeter Soln SA | Noriko Yokozuka | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 12 Dec 2025 | 120,000 | 184,657 | - | 10 | 1,200,000 | Common Stock |
| Artiva Biotherapeutics Inc | Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 113,999 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Alignment Healthcare Inc | Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 12 Dec 2025 | 113,319 | 1,667,237 | - | 20.0 | 2,267,151 | Common Stock |
| Merus N.V | Gregory D. Perry | Chief Financial Officer & PFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 107,300 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Peter B. Silverman | COO & GC | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 107,300 | 0 | - | - | Share Option (right to buy) | |
| Artiva Biotherapeutics Inc | Christopher Horan | Chief Tech Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 107,156 | 185,339 | - | 0 | Common Stock | |
| Merus N.V | Peter B. Silverman | COO & GC | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 104,000 | 0 | - | - | Share Option (right to buy) | |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 104,000 | 1,287,366 (1%) | 0% | 0 | Air Lease Corporation - Class A Common Stock | |
| Artiva Biotherapeutics Inc | Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 100,577 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Arrowhead Pharma Inc | Christopher Anzalone | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 68.67 per share. | 12 Dec 2025 | 100,532 | 4,000,723 (3%) | 0% | 68.7 | 6,903,532 | Common Stock |
| Chipotle Mexican Grill | Curtis Evander Garner | Pres, Chief Strgy & Tech Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 100,000 | 86,100 | - | - | 2019 SOSARs | |
| Chipotle Mexican Grill | Curtis Evander Garner | Pres, Chief Strgy & Tech Off | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.66 per share. | 12 Dec 2025 | 100,000 | 398,360 (1%) | 0% | 11.7 | 1,165,500 | common stock |
| Merus N.V | Gregory D. Perry | Chief Financial Officer & PFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 100,000 | 0 | - | - | Share Option (right to buy) | |
| DocGo Inc | Ely D. Tendler | Director, General Counsel and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 100,000 | 275,645 | - | 0 | Common Stock | |
| Perimeter Soln SA | Kyle Sable | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 100,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Perimeter Soln SA | Kyle Sable | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 28.47 per share. | 12 Dec 2025 | 100,000 | 0 | - | 28.5 | 2,847,000 | Common Stock |
| Perimeter Soln SA | Kyle Sable | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.36 per share. | 12 Dec 2025 | 100,000 | 100,000 | - | 8.4 | 836,000 | Common Stock |
| Anywhere Real Estate Inc | Ryan M. Schneider | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 94,232 | 2,762,876 (2%) | 0% | 14.6 | 1,374,845 | Common Stock, $0.01 par value |
| Anywhere Real Estate Inc | Ryan M. Schneider | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 89,590 | 2,673,286 (2%) | 0% | 14.6 | 1,307,118 | Common Stock, $0.01 par value |
| Anywhere Real Estate Inc | Susan Yannaccone | Pres/CEO AW Brands AW Advisors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 88,342 | 527,254 (0%) | 0% | 14.6 | 1,288,910 | Common Stock, $0.01 par value |
| CubeSmart | Christopher P. Marr | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.32 per share. | 12 Dec 2025 | 87,604 | 628,795 (0%) | 0% | 30.3 | 2,656,153 | Common |
| CubeSmart | Christopher P. Marr | Director, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 87,604 | 0 | - | - | Stock Option (right to buy) | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 84,877 | 232,925 | - | 0 | Common Stock | |
| Merus N.V | Peter B. Silverman | COO & GC | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 83,000 | 0 | - | - | Share Option (right to buy) | |
| Lumexa Imaging Holdings Inc | Julie Szeker | Chief Legal Officer & Corp Sec | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 81,081 | 147,263 | - | 0 | Common Stock | |
| Harrow Health Inc | Mark L. Baum | Director, CHIEF EXECUTIVE OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.06 per share. | 12 Dec 2025 | 79,994 | 2,986,130 (11%) | 0% | 47.1 | 3,764,518 | Common Stock |
| Artiva Biotherapeutics Inc | Christopher Horan | Chief Tech Operations Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 77,519 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Karman Holdings Inc | Anthony Koblinski | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.31 per share. | 12 Dec 2025 | 75,000 | 2,315,826 | - | 69.3 | 5,198,250 | Common Stock |
| Traws Pharma Inc | Charles David Pauza | Chief Science Officer Virology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 73,886 | 73,886 | - | - | Stock Option (right to purchase) | |
| Merus N.V | Mark T. Iwicki | Director | 12 Dec 2025 | 73,576 | 0 (0%) | 0% | 97 | 7,136,872 | Common Shares | |
| BCP Investment Corp | Edward Goldthorpe | Director, President, CEO | Purchase of securities on an exchange or from another person at price $ 13.63 per share. | 12 Dec 2025 | 73,367 | 86,140 (0%) | 0% | 13.6 | 999,992 | Common Stock |
| Chipotle Mexican Grill | Curtis Evander Garner | Pres, Chief Strgy & Tech Off | Sale of securities on an exchange or to another person at price $ 36.05 per share. | 12 Dec 2025 | 67,646 | 298,360 (1%) | 0% | 36.0 | 2,438,422 | common stock |
| Artiva Biotherapeutics Inc | Heather Raymon | SVP, Research and Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 67,253 | 106,844 | - | 0 | Common Stock | |
| Lumexa Imaging Holdings Inc | Julie Szeker | Chief Legal Officer & Corp Sec | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 66,182 | 66,182 | - | - | Common Stock | |
| DocGo Inc | Norman Rosenberg | CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.91 per share. | 12 Dec 2025 | 65,774 | 1,223,571 | - | 0.9 | 59,854 | Common Stock |
| Traws Pharma Inc | Robert R Redfield | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 65,676 | 65,676 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc | Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 65,676 | 65,676 | - | - | Stock Option (right to purchase) | |
| Lumexa Imaging Holdings Inc | Caitlin Zulla | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 64,864 | 129,728 | - | 0 | Common Stock | |
| Lumexa Imaging Holdings Inc | Caitlin Zulla | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 64,864 | 64,864 | - | 0 | Common Stock | |
| G-III Apparel Grp Ltd | Dana M. Perlman | Chief Grwth Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 63,673 | 84,386 (0%) | 0% | 0 | Common Stock, Par Value $.01 Per Share | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 60,975 | 289,751 (0%) | 0% | - | Common Stock | |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 60,975 | 60,976 | - | - | Restricted Stock Units | |
| Harrow Health Inc | Andrew R. Boll | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 60,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Harrow Health Inc | Andrew R. Boll | PRESIDENT AND CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. | 12 Dec 2025 | 60,000 | 837,844 (3%) | 0% | 4.0 | 237,000 | Common Stock |
| Hain Celestial Grp Inc | Michael J. Ragusa | SVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 53,334 | 53,334 | - | - | Restricted Share Units | |
| Vera Bradley Inc | Ian Martin Bickley | Director | Purchase of securities on an exchange or from another person at price $ 1.94 per share. | 12 Dec 2025 | 53,000 | 841,629 (2%) | 0% | 1.9 | 103,032 | Common Shares |
| Arch Capital | John M. Pasquesi | Director, CHAIR | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 53,000 | 298,356 (0%) | 0% | 0 | Common Shares, $.0011 par value per share | |
| Marqeta Inc (Class A) | Jason Gardner | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.00 per share. | 12 Dec 2025 | 52,551 | 14,924,822 | - | 5 | 262,755 | Class A Common Stock |
| Laureate Education Inc | Eilif Serck-Hanssen | Director, PRESIDENT & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 32.68 per share. | 12 Dec 2025 | 52,510 | 1,150,065 | - | 32.7 | 1,716,027 | Common Stock |
| Biomerica Inc | Zachary S. Irani | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 52,500 | 211,320 (2%) | 0% | 0 | Common stock | |
| Monster Beverage | Rodney C. Sacks | Director | Sale of securities on an exchange or to another person at price $ 73.58 per share. | 12 Dec 2025 | 52,342 | 0 (0%) | 0% | 73.6 | 3,851,324 | Common Stock |
| Century Therapeutics Inc | Brent Pfeiffenberger | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.58 per share. | 12 Dec 2025 | 52,000 | 3,322,990 | - | 0.6 | 30,352 | Common Stock |
| Artiva Biotherapeutics Inc | Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 51,463 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Merus N.V | Peter B. Silverman | COO & GC | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 50,000 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Fabian Zohren | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 50,000 | 0 | - | - | Share Option (right to buy) | |
| authID Inc | Stephen Jeffrey Garchik | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.06 per share. | 12 Dec 2025 | 50,000 | 1,073,563 (0%) | 0% | 1.1 | 53,000 | Common Stock |
| Ovintiv Inc | Gregory Dean Givens | EVP & COO | Sale of securities on an exchange or to another person at price $ 40.33 per share. | 12 Dec 2025 | 50,000 | 105,867 (0%) | 0% | 40.3 | 2,016,500 | Common Stock |
| Vera Bradley Inc | Andrew M. Meslow | Director | Purchase of securities on an exchange or from another person at price $ 1.93 per share. | 12 Dec 2025 | 50,000 | 600,000 (1%) | 0% | 1.9 | 96,455 | Common Shares |
| Snowflake Inc (Class A) | Benoit Dageville | Director, Founder and Chief Architect | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 50,000 | 3,001,555 | - | 0 | Common Stock | |
| SEI Investments Co. | Michael Lane | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 49,650 | 49,650 | - | - | Option to Purchase Common Stock | |
| SEI Investments Co. | Sean Denham | Executive Vice President, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 49,000 | 49,000 | - | - | Option to Purchase Common Stock | |
| Zurn Elkay Water Soln Corp | Todd A. Adams | Director, Chairman and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 47,000 | 2,225,347 (1%) | 0% | 0 | Common Stock | |
| SEI Investments Co. | Philip N. McCabe | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 47,000 | 47,000 | - | - | Option to Purchase Common Stock | |
| SEI Investments Co. | Sanjay K. Sharma | See Remarks* | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 47,000 | 47,000 | - | - | Option to Purchase Common Stock | |
| CubeSmart | Christopher P. Marr | Director, CEO | Sale of securities on an exchange or to another person at price $ 36.55 per share. | 12 Dec 2025 | 46,925 | 581,870 (0%) | 0% | 36.6 | 1,715,109 | Common |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.91 per share. | 12 Dec 2025 | 45,000 | 29,018,585 | - | 17.9 | 805,775 | Class A Commmon Stock |
| UiPath Inc (Class A) | Daniel Dines | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 17.30 per share. | 12 Dec 2025 | 45,000 | 28,973,585 | - | 17.3 | 778,437 | Class A Commmon Stock |
| Ally Fin Inc | Michael G. Rhodes | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 45.82 per share. | 12 Dec 2025 | 44,638 | 290,947 (0%) | 0% | 45.8 | 2,045,313 | Common Stock |
| Anywhere Real Estate Inc | Susan Yannaccone | Pres/CEO AW Brands AW Advisors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 44,222 | 615,596 (0%) | 0% | 14.6 | 645,199 | Common Stock, $0.01 par value |
| SEI Investments Co. | Michael N. Peterson | EXECUTIVE VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 43,000 | 43,000 | - | - | Option to Purchase Common Stock | |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 41,039 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Spectrum Brands Holdings Inc | David Maura | Director, Executive Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 40,179 | 788,208 (1%) | 0% | 0 | Common Stock | |
| Sensus Healthcare Inc | Michael Sardano | Director, PRESIDENT AND GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 40,000 | 158,839 | - | 0 | Common Stock | |
| Hycroft Mining Holding Corp (Class A) | Eric Steven Sprott | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 13.30 per share. | 12 Dec 2025 | 40,000 | 29,986,352 | - | 13.3 | 532,000 | Class A common stock |
| Biomerica Inc | Gary Lu | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 40,000 | 59,375 (0%) | 0% | 0 | Common stock | |
| Viasat Inc | Shawn Duffy | SVP, Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 36.28 per share. | 12 Dec 2025 | 39,970 | 17,531 (0%) | 0% | 36.3 | 1,450,172 | $.0001 par value common stock |
| LifeStance Health Grp Inc | Robert Bessler | Director | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 12 Dec 2025 | 39,815 | 1,498,975 | - | 7.0 | 279,103 | Common Stock |
| LifeStance Health Grp Inc | Robert Bessler | Director | Sale of securities on an exchange or to another person at price $ 7.01 per share. | 12 Dec 2025 | 39,815 | 1,382,175 | - | 7.0 | 279,103 | Common Stock |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Sale of securities on an exchange or to another person at price $ 475.20 per share. | 12 Dec 2025 | 37,880 | 193,226 (0%) | 0% | 475.2 | 18,000,576 | Class A Common Stock |
| Traws Pharma Inc | Iain D. Dukes | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 36,943 | 171,130 (0%) | 0% | 0 | Common Stock | |
| DocGo Inc | Stephen Sugrue | Chief Compliance Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.91 per share. | 12 Dec 2025 | 35,968 | 636,602 | - | 0.9 | 32,731 | Common Stock |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 91.24 per share. | 12 Dec 2025 | 35,898 | 349,603 | - | 91.2 | 3,275,334 | Common Stock |
| Apple Hospitality REIT Inc | Justin G. Knight | Director, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.12 per share. | 12 Dec 2025 | 35,426 | 1,934,599 (0%) | 0% | 12.1 | 429,363 | Common Shares |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 34,999 | 34,999 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 34,999 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Anywhere Real Estate Inc | Charlotte C Simonelli | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 34,021 | 734,487 (0%) | 0% | 14.6 | 496,366 | Common Stock, $0.01 par value |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.07 per share. | 12 Dec 2025 | 33,732 | 224,838 (0%) | 0% | 10.1 | 339,681 | Class A Common Stock |
| Carvana Co. (Class A) | Daniel Gill | Chief Product Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 33,732 | 167,170 | - | - | Stock Options (Right to Buy) | |
| Blink Charging Co | Michael C. Battaglia | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.75 per share. | 12 Dec 2025 | 33,333 | 267,095 (1%) | 0% | 0.8 | 25,000 | Common Stock, par value $0.001 per share |
| Blink Charging Co | Michael Bercovich | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.75 per share. | 12 Dec 2025 | 33,333 | 156,563 (0%) | 0% | 0.8 | 25,000 | Common Stock, par value $0.001 per share |
| authID Inc | Thomas R. Szoke | Chief Technology Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 32,987 | 17,013 | - | - | Stock Options | |
| Chipotle Mexican Grill | Curtis Evander Garner | Pres, Chief Strgy & Tech Off | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.03 per share. | 12 Dec 2025 | 32,354 | 366,006 (1%) | 0% | 36.0 | 1,165,715 | common stock |
| Blink Charging Co | Michael Bercovich | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.79 per share. | 12 Dec 2025 | 32,000 | 188,563 (0%) | 0% | 0.8 | 25,392 | Common Stock, par value $0.001 per share |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.15 per share. | 12 Dec 2025 | 30,964 | 258,787 (0%) | 0% | 75.2 | 2,326,945 | Common Stock |
| Merus N.V | Sven Ante Lundberg | Director, President, CEO & PEO | 12 Dec 2025 | 30,297 | 0 (0%) | 0% | 97 | 2,938,809 | Common Shares | |
| KLX Energy Services Holdings Inc | Geoffrey C. Stanford | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.94 per share. | 12 Dec 2025 | 30,000 | 57,262 (0%) | 0% | 1.9 | 58,200 | Common stock |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.46 per share. | 12 Dec 2025 | 30,000 | 1,474,034 (4%) | 0% | 6.5 | 193,680 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.46 per share. | 12 Dec 2025 | 30,000 | 1,474,034 (4%) | 0% | 6.5 | 193,680 | Common Stock |
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | 12 Dec 2025 | 30,000 | 2,329,296 | - | - | Class B Common Stock | ||
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 30,000 | 2,029,073 | - | - | Stock Option (Right to Buy) | |
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 12 Dec 2025 | 30,000 | 0 | - | 90 | 2,700,000 | Class A Common Stock |
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | 12 Dec 2025 | 30,000 | 30,000 | - | - | Class A Common Stock | ||
| Monster Beverage | Emelie C. Tirre | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 73.31 per share. | 12 Dec 2025 | 30,000 | 63,939 (0%) | 0% | 73.3 | 2,199,300 | Common Stock |
| Biomerica Inc | Allen C. Barbieri | Director, Executive Vice-Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 30,000 | 53,543 (0%) | 0% | 0 | Common stock | |
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | 12 Dec 2025 | 30,000 | 30,000 | - | - | Class A Common Stock | ||
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 30,000 | 2,029,073 | - | - | Stock Option (Right to Buy) | |
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 30,000 | 2,389,296 | - | - | Class B Common Stock | |
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | 12 Dec 2025 | 30,000 | 2,359,296 | - | - | Class B Common Stock | ||
| Circle Internet Grp Inc (Class A) | P. Sean Neville | Director | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 12 Dec 2025 | 30,000 | 30,000 | - | 90 | 2,700,000 | Class A Common Stock |
| CubeSmart | Timothy M. Martin | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 29,566 | 0 | - | - | Stock Option (right to buy) | |
| CubeSmart | Timothy M. Martin | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.32 per share. | 12 Dec 2025 | 29,566 | 358,795 (0%) | 0% | 30.3 | 896,441 | Common |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 91.18 per share. | 12 Dec 2025 | 28,913 | 389,422 | - | 91.2 | 2,636,287 | Common Stock |
| Arch Capital | John M. Pasquesi | Director, CHAIR | Sale of securities on an exchange or to another person at price $ 93.81 per share. | 12 Dec 2025 | 28,866 | 526,356 (0%) | 0% | 93.8 | 2,707,902 | Common Shares, $.0011 par value per share |
| Ultralife Corp | Bradford T. Whitmore | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.70 per share. | 12 Dec 2025 | 28,588 | 1,235,631 (7%) | 0% | 5.7 | 163,026 | Common Stock |
| Ametek | David A. Zapico | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 28,390 | 317,051 (0%) | 0% | 0 | Common Stock | |
| Ametek | David A. Zapico | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 201.76 per share. | 12 Dec 2025 | 28,390 | 0 (0%) | 0% | 201.8 | 5,727,966 | Common Stock |
| BridgeBio Pharma Inc | Neil Kumar | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 74.60 per share. | 12 Dec 2025 | 28,311 | 230,476 (0%) | 0% | 74.6 | 2,111,992 | Common Stock |
| Morningstar Inc | Joseph D. Mansueto | Director, Executive Chairman, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 27,775 | 8,238,232 (19%) | 0% | 0 | Common Stock | |
| Merus N.V | Harry Shuman | VP Controller, PAO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 27,550 | 0 | - | - | Share Option (right to buy) | |
| Relmada Therapeutics Inc | Sergio Traversa | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 4.12 per share. | 12 Dec 2025 | 27,500 | 1,300,000 (8%) | 0% | 4.1 | 113,300 | Common Stock |
| Biocryst Pharma Inc | Jon P. Stonehouse | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.57 per share. | 12 Dec 2025 | 27,368 | 1,405,222 (0%) | 0% | 7.6 | 207,176 | Common Stock |
| Atlas Lithium Corp | Marc Fogassa | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 4.35 per share. | 12 Dec 2025 | 27,272 | 4,552,924 | - | 4.4 | 118,750 | Common Stock |
| Raymond James Financial | Tashtego S. Elwyn | President, PCG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 27,203 | 20,312 | - | - | Restricted Stock Units | |
| Raymond James Financial | Tashtego S. Elwyn | President, PCG | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 27,203 | 63,431 (0%) | 0% | 0 | Common Stock | |
| Lumexa Imaging Holdings Inc | Molly E. Joseph | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 27,027 | 27,027 | - | 0 | Common Stock | |
| Harrow Health Inc | Andrew R. Boll | PRESIDENT AND CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.06 per share. | 12 Dec 2025 | 26,665 | 811,179 (3%) | 0% | 47.1 | 1,254,855 | Common Stock |
| Artiva Biotherapeutics Inc | Fred Aslan | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 26,450 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Sale of securities on an exchange or to another person at price $ 64.02 per share. | 12 Dec 2025 | 26,000 | 74,000 (0%) | 0% | 64.0 | 1,664,512 | Air Lease Corporation - Class A Common Stock |
| SEI Investments Co. | Ryan P. Hicke | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 25,904 | 197,163 (0%) | 0% | - | Common Stock | |
| Aptiv | Kevin P. Clark | Director, Chair and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 25,320 | 643,222 (0%) | 0% | 0 | Ordinary Shares | |
| Anywhere Real Estate Inc | Charlotte C Simonelli | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 25,200 | 768,508 (0%) | 0% | 14.6 | 367,668 | Common Stock, $0.01 par value |
| Anywhere Real Estate Inc | Susan Yannaccone | Pres/CEO AW Brands AW Advisors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 25,198 | 659,818 (0%) | 0% | 14.6 | 367,639 | Common Stock, $0.01 par value |
| CNB Fin Corp (PA) | Gary S. Olson | Director | Sale of securities on an exchange or to another person at price $ 27.75 per share. | 12 Dec 2025 | 25,000 | 52,808 (0%) | 0% | 27.8 | 693,750 | Common Stock |
| Warby Parker Inc (Class A) | Jeffrey Raider | Director | Sale of securities on an exchange or to another person at price $ 27.42 per share. | 12 Dec 2025 | 25,000 | 483,485 | - | 27.4 | 685,500 | Class A Common Stock |
| Photronics Inc | Christopher J. Progler | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 35.78 per share. | 12 Dec 2025 | 25,000 | 165,591 (0%) | 0% | 35.8 | 894,500 | Common Stock |
| Traws Pharma Inc | Jack E. Stover | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 24,629 | 24,629 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc | Mary Teresa Shoemaker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 24,629 | 24,629 | - | - | Stock Option (right to purchase) | |
| Traws Pharma Inc | Trafford Clarke | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 24,629 | 24,629 | - | - | Stock Option (right to purchase) | |
| Ouster Inc (Class A) | Angus Pacala | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 24.98 per share. | 12 Dec 2025 | 24,610 | 985,317 | - | 25.0 | 614,689 | Common Stock |
| Airbnb | Brian Chesky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 131.57 per share. | 12 Dec 2025 | 24,567 | 48,814 | - | 131.6 | 3,232,378 | Class A Common Stock |
| Essex Property - REIT | Angela L. Kleiman | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 23,974 | 37,636 (0%) | 0% | 0 | Common Stock | |
| Privia Health Group Inc | David Mountcastle | EVP & Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.03 per share. | 12 Dec 2025 | 23,887 | 172,909 | - | 25.0 | 597,892 | Common Stock, par value $0.01 per share |
| Privia Health Group Inc | David Mountcastle | EVP & Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. | 12 Dec 2025 | 23,887 | 196,796 | - | 2 | 47,774 | Common Stock, par value $0.01 per share |
| Circle Internet Grp Inc (Class A) | Jeremy Fox-Geen | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 90.00 per share. | 12 Dec 2025 | 23,830 | 282,173 | - | 90 | 2,144,700 | Class A Common Stock |
| Equillium Inc | Christine Zedelmayer | Sr. Vice President and COO | Sale of securities on an exchange or to another person at price $ 1.34 per share. | 12 Dec 2025 | 23,804 | 103,344 (0%) | 0% | 1.3 | 31,897 | Common Stock |
| Pagaya Tech Ltd (Class A) | Sanjiv Das | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 23,750 | 118,750 | - | - | Restricted Stock Unit | |
| Pagaya Tech Ltd (Class A) | Sanjiv Das | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 23,750 | 134,490 | - | 0 | Class A Ordinary Share | |
| Airbnb | Brian Chesky | Director, CEO and Chairman, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 130.63 per share. | 12 Dec 2025 | 23,703 | 73,381 | - | 130.6 | 3,096,330 | Class A Common Stock |
| Compass Inc (Class A) | Scott Wahlers | CFO | Sale of securities on an exchange or to another person at price $ 11.00 per share. | 12 Dec 2025 | 23,500 | 340,225 | - | 11.0 | 258,585 | Class A Common Stock |
| Hyliion Holdings Corporation | Jose Miguel Oxholm | Chief Legal&Compliance Officer | Other type of transaction at price $ 1.94 per share. | 12 Dec 2025 | 23,422 | 755,628 | - | 1.9 | 45,439 | Common Stock |
| Merus N.V | Harry Shuman | VP Controller, PAO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 23,420 | 0 | - | - | Share Option (right to buy) | |
| Anywhere Real Estate Inc | Rudy Wolfs | EVP, Chief Technology Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 22,680 | 222,906 (0%) | 0% | 14.6 | 330,901 | Common Stock, $0.01 par value |
| Natera Inc | Solomon Moshkevich | PRESIDENT, CLINICALDIAGNOSTICS | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 22,376 | 5,125 | - | - | Stock Option (right to buy) | |
| JFrog Ltd | Yoav Landman | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 69.16 per share. | 12 Dec 2025 | 22,245 | 5,918,154 | - | 69.2 | 1,538,464 | Ordinary Shares |
| Anywhere Real Estate Inc | Charlotte C Simonelli | EVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 22,088 | 793,708 (0%) | 0% | 14.6 | 322,264 | Common Stock, $0.01 par value |
| Anywhere Real Estate Inc | Susan Yannaccone | Pres/CEO AW Brands AW Advisors | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 22,086 | 685,016 (0%) | 0% | 14.6 | 322,235 | Common Stock, $0.01 par value |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 21,999 | 21,999 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | William P. Quinn | Director, President, CEO and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 21,999 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| American Airlines Grp Inc | David Seymour | EVP Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.96 per share. | 12 Dec 2025 | 21,985 | 957,791 (0%) | 0% | 15.0 | 328,896 | Common Stock |
| SiriusPoint Ltd | Scott Egan | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 12 Dec 2025 | 21,801 | 784,166 (0%) | 0% | 0 | Common Shares | |
| Arrowhead Pharma Inc | Christopher Anzalone | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 69.28 per share. | 12 Dec 2025 | 21,321 | 3,979,402 (3%) | 0% | 69.3 | 1,477,119 | Common Stock |
| Mannkind Corp | Michael E. Castagna | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 21,310 | 15,804 | - | - | Employee Stock Option (Right to Buy) | |
| Mannkind Corp | Michael E. Castagna | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 12 Dec 2025 | 21,310 | 2,504,792 (1%) | 0% | 6 | 127,860 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Michael E. Castagna | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.55 per share. | 12 Dec 2025 | 21,310 | 2,526,102 (1%) | 0% | 4.6 | 96,961 | Common Stock, $0.01 Par Value |
| Biocryst Pharma Inc | Alane P. Barnes | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.65 per share. | 12 Dec 2025 | 21,210 | 315,726 (0%) | 0% | 7.7 | 162,257 | Common Stock |
| AvePoint Inc (Class A) | Brian Michael Brown | Director, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 21,000 | 2,265,102 | - | - | Stock Option (Right to Buy) | |
| AvePoint Inc (Class A) | Brian Michael Brown | Director, Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.89 per share. | 12 Dec 2025 | 21,000 | 645,048 | - | 13.9 | 291,690 | Common Stock |
| Mannkind Corp | Michael E. Castagna | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.55 per share. | 12 Dec 2025 | 20,806 | 2,525,598 (1%) | 0% | 4.5 | 94,667 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Michael E. Castagna | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.00 per share. | 12 Dec 2025 | 20,806 | 2,504,792 (1%) | 0% | 6 | 124,836 | Common Stock, $0.01 Par Value |
| Viasat Inc | Shawn Duffy | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,695 | 22,805 | - | - | employee stock option (right to buy) | |
| Viasat Inc | Shawn Duffy | SVP, Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.96 per share. | 12 Dec 2025 | 20,695 | 57,501 (0%) | 0% | 16.0 | 330,292 | $.0001 par value common stock |
| Air Lease Corp (Class A) | Kishore Korde | EVP | Sale of securities on an exchange or to another person at price $ 64.10 per share. | 12 Dec 2025 | 20,662 | 50,091 (0%) | 0% | 64.1 | 1,324,434 | Air Lease Corporation - Class A Common Stock |
| Pagaya Tech Ltd (Class A) | Evangelos Perros | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,625 | 103,125 | - | - | Restricted Stock Unit | |
| Pagaya Tech Ltd (Class A) | Evangelos Perros | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,625 | 98,788 | - | 0 | Class A Ordinary Share | |
| Ball Corp | Scott Arthur Vail | SVP & CSCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 20,623 | 20,623 | - | - | Restricted Stock Units | |
| Voya Fin Inc | Michael Robert Katz | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 37.60 per share. | 12 Dec 2025 | 20,600 | 60,696 (0%) | 0% | 37.6 | 774,560 | Common Stock |
| Voya Fin Inc | Michael Robert Katz | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,600 | 35,587 | - | - | Performance-Based Stock Options | |
| Voya Fin Inc | Michael Robert Katz | See Remarks | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 12 Dec 2025 | 20,600 | 40,096 (0%) | 0% | 75 | 1,545,000 | Common Stock |
| Artiva Biotherapeutics Inc | Jennifer Kinsbruner Bush | COO, CLO, Secy, Compliance Off | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 20,519 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Artiva Biotherapeutics Inc | Christopher Horan | Chief Tech Operations Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 20,519 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Cadre Holdings Inc | Blaine Browers | CHIEF FINANCIAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.79 per share. | 12 Dec 2025 | 20,435 | 63,142 | - | 43.8 | 894,849 | Common Stock, par value $0.0001 per share ("Common Stock") |
| Carvana Co. (Class A) | Benjamin Huston | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 348,513 | - | - | Stock Options (Right to Buy) | |
| Carvana Co. (Class A) | Benjamin Huston | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 475.00 per share. | 12 Dec 2025 | 20,000 | 100,758 (0%) | 0% | 475 | 9,500,000 | Class A Common Stock |
| Carvana Co. (Class A) | Benjamin Huston | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.07 per share. | 12 Dec 2025 | 20,000 | 120,758 (0%) | 0% | 10.1 | 201,400 | Class A Common Stock |
| Merus N.V | Peter B. Silverman | COO & GC | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 0 | - | - | Share Option (right to buy) | |
| PaySign Inc | Robert P. Strobo | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.47 per share. | 12 Dec 2025 | 20,000 | 327,290 (0%) | 0% | 5.5 | 109,400 | Common Stock |
| KLX Energy Services Holdings Inc | Geoffrey C. Stanford | See Remarks | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 12 Dec 2025 | 20,000 | 77,262 (0%) | 0% | 1.9 | 37,000 | Common stock |
| VYNE Therapeutics Inc | Patrick G. LePore | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| VYNE Therapeutics Inc | Sharon Barbari | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| VYNE Therapeutics Inc | Steven L. Basta | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| VYNE Therapeutics Inc | Elisabeth A. Sandoval Little | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Sale of securities on an exchange or to another person at price $ 64.02 per share. | 12 Dec 2025 | 20,000 | 2,660,000 (2%) | 0% | 64.0 | 1,280,400 | Air Lease Corporation - Class A Common Stock |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Sale of securities on an exchange or to another person at price $ 64.14 per share. | 12 Dec 2025 | 20,000 | 2,640,000 (2%) | 0% | 64.1 | 1,282,852 | Air Lease Corporation - Class A Common Stock |
| AMKOR Tech Inc | Gil C. Tily | Director | Sale of securities on an exchange or to another person at price $ 46.44 per share. | 12 Dec 2025 | 20,000 | 123,806 (0%) | 0% | 46.4 | 928,800 | Common Stock |
| AMKOR Tech Inc | MaryFrances McCourt | Director | Sale of securities on an exchange or to another person at price $ 46.02 per share. | 12 Dec 2025 | 20,000 | 55,918 (0%) | 0% | 46.0 | 920,400 | Common Stock |
| AMKOR Tech Inc | MaryFrances McCourt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.39 per share. | 12 Dec 2025 | 20,000 | 75,918 (0%) | 0% | 19.4 | 387,800 | Common Stock |
| AMKOR Tech Inc | MaryFrances McCourt | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 0 | - | - | Director Stock Option (Right-to-Buy) | |
| Bit Digital Inc | Brock J. Pierce | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 20,000 | - | - | Restricted Share Units | |
| Bit Digital Inc | Brock J. Pierce | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 600,000 (4%) | 0% | - | Ordinary Shares, $.01 par value | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 128,497 | - | - | Options to purchase common stock | |
| Catalyst Pharma Inc | Molly Harper | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.78 per share. | 12 Dec 2025 | 20,000 | 29,106 (0%) | 0% | 5.8 | 115,600 | Common stock, par value $0.001 per share |
| Gogo Inc | Oakleigh Thorne | Director, Executive Chair, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.24 per share. | 12 Dec 2025 | 20,000 | 804,098 (0%) | 0% | 5.2 | 104,800 | Common Stock |
| Photronics Inc | Kang Jyh Lee | Director | Sale of securities on an exchange or to another person at price $ 38.53 per share. | 12 Dec 2025 | 20,000 | 493,350 (0%) | 0% | 38.5 | 770,600 | COMMON STOCK |
| Photronics Inc | Kang Jyh Lee | Director | Sale of securities on an exchange or to another person at price $ 36.45 per share. | 12 Dec 2025 | 20,000 | 493,350 (0%) | 0% | 36.5 | 729,000 | COMMON STOCK |
| Photronics Inc | Kang Jyh Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.35 per share. | 12 Dec 2025 | 20,000 | 513,350 (0%) | 0% | 11.4 | 227,000 | COMMON STOCK |
| Photronics Inc | Kang Jyh Lee | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 0 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 12 Dec 2025 | 20,000 | 20,000 | - | 8.2 | 164,400 | Common Stock |
| Harmony Biosciences Holdings Inc | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 0 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Jeffrey M. Dayno | Director, PRESIDENT, CEO | Sale of securities on an exchange or to another person at price $ 40.11 per share. | 12 Dec 2025 | 20,000 | 0 | - | 40.1 | 802,146 | Common Stock |
| Biomerica Inc | David Moatazedi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 30,625 (0%) | 0% | 0 | Common stock | |
| Biomerica Inc | Gary M. Huff | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 20,000 | 20,000 (0%) | 0% | 0 | Common stock | |
| HubSpot Inc | Dharmesh Shah | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 19,990 | 0 | - | - | Stock Option (right to buy) | |
| HubSpot Inc | Dharmesh Shah | Director, Chief Technology Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 40.59 per share. | 12 Dec 2025 | 19,990 | 1,290,144 (2%) | 0% | 40.6 | 811,394 | Common Stock |
| TriplePoint Venture Growth BDC Corp | James P. Labe | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.64 per share. | 12 Dec 2025 | 19,919 | 1,444,034 (4%) | 0% | 6.6 | 132,292 | Common Stock |
| TriplePoint Venture Growth BDC Corp | Sajal K. Srivastava | Director, President and CIO | Purchase of securities on an exchange or from another person at price $ 6.64 per share. | 12 Dec 2025 | 19,919 | 1,444,034 (4%) | 0% | 6.6 | 132,292 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Sale of securities on an exchange or to another person at price $ 6.27 per share. | 12 Dec 2025 | 19,793 | 11,206 (0%) | 0% | 6.3 | 124,181 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.16 per share. | 12 Dec 2025 | 19,793 | 30,999 (0%) | 0% | 4.2 | 82,339 | Common Stock |
| Galectin Therapeutics Inc | Harold H. Shlevin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 19,793 | 53,417 | - | - | Stock Option (right to buy) | |
| Traws Pharma Inc | Werner Cautreels | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 19,496 | 19,496 | - | - | Stock Option (right to purchase) | |
| Southern Calif Bancorp | Thomas G. Dolan | EVP / Bancorp CFO/ CSO | Other type of transaction at price $ 0.00 per share. | 12 Dec 2025 | 19,346 | 30,301 | - | 0 | Common Stock | |
| Southern Calif Bancorp | Thomas G. Dolan | EVP / Bancorp CFO/ CSO | Other type of transaction at price $ 0.00 per share. | 12 Dec 2025 | 19,346 | 260,159 | - | 0 | Common Stock | |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Sale of securities on an exchange or to another person at price $ 64.23 per share. | 12 Dec 2025 | 19,132 | 956,526 (0%) | 0% | 64.2 | 1,228,919 | Air Lease Corporation - Class A Common Stock |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Sale of securities on an exchange or to another person at price $ 64.12 per share. | 12 Dec 2025 | 19,000 | 1,391,366 (1%) | 0% | 64.1 | 1,218,373 | Air Lease Corporation - Class A Common Stock |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 91.24 per share. | 12 Dec 2025 | 18,666 | 337,698 | - | 91.2 | 1,703,086 | Common Stock |
| East West Bancorp Inc | Dominic Ng | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 113.22 per share. | 12 Dec 2025 | 18,656 | 869,658 (0%) | 0% | 113.2 | 2,112,232 | Common Stock |
| PC Connection Inc | Patricia Gallup | Director, Chairman & Chief Admin Officer, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 18,500 | 2,522,008 (9%) | 0% | 0 | Common Stock | |
| Traws Pharma Inc | Charles David Pauza | Chief Science Officer Virology | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 18,471 | 115,971 (0%) | 0% | 0 | Common Stock | |
| BV Fin Inc | Michael J. Dee | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.65 per share. | 12 Dec 2025 | 18,371 | 51,585 | - | 5.6 | 103,796 | Common Stock |
| BV Fin Inc | Michael J. Dee | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 18,371 | 0 | - | - | Stock Options | |
| JFrog Ltd | Yoav Landman | Director, CHIEF TECHNOLOGY OFFICER | Sale of securities on an exchange or to another person at price $ 68.12 per share. | 12 Dec 2025 | 18,242 | 5,940,399 | - | 68.1 | 1,242,645 | Ordinary Shares |
| Artiva Biotherapeutics Inc | Heather Raymon | SVP, Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 18,239 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Walt Disney | James P. Gorman | Director | Purchase of securities on an exchange or from another person at price $ 111.89 per share. | 12 Dec 2025 | 18,000 | 38,000 (0%) | 0% | 111.9 | 2,013,943 | Disney Common Stock |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Sale of securities on an exchange or to another person at price $ 63.99 per share. | 12 Dec 2025 | 18,000 | 1,410,366 (1%) | 0% | 64.0 | 1,151,818 | Air Lease Corporation - Class A Common Stock |
| Air Lease Corp (Class A) | Steven F. Udvar-Hazy | Director | Sale of securities on an exchange or to another person at price $ 64.01 per share. | 12 Dec 2025 | 18,000 | 975,658 (0%) | 0% | 64.0 | 1,152,189 | Air Lease Corporation - Class A Common Stock |
| Anywhere Real Estate Inc | Tanya Reu-Narvaez | EVP, Chief People Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.59 per share. | 12 Dec 2025 | 17,689 | 207,832 (0%) | 0% | 14.6 | 258,083 | Common Stock, $0.01 par value |
| Merus N.V | Jason Haddock | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 17,688 | 0 | - | - | Share Option (right to buy) | |
| Perimeter Soln SA | Noriko Yokozuka | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.00 per share. | 12 Dec 2025 | 17,500 | 64,657 | - | 10 | 175,000 | Common Stock |
| Perimeter Soln SA | Noriko Yokozuka | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 17,500 | 0 | - | - | Stock Option (right to buy) | |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Operating Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 17,499 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Bolt Biotherapeutics Inc | Grant A. Yonehiro | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 17,499 | 17,499 | - | - | Employee Stock Option (Right to Buy) | |
| Merus N.V | Paolo Pucci | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 17,262 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Gregory D. Perry | Chief Financial Officer & PFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 17,000 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Anand Mehra | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 17,000 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Victor Sandor | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 17,000 | 0 | - | - | Share Option (right to buy) | |
| Exxon Mobil | Michael J. Angelakis | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 17,000 | 21,000 (0%) | 0% | 0 | Common Stock | |
| Monster Beverage | Rodney C. Sacks | Director | Sale of securities on an exchange or to another person at price $ 73.58 per share. | 12 Dec 2025 | 16,997 | 360,948 (0%) | 0% | 73.6 | 1,250,639 | Common Stock |
| DocGo Inc | Ely D. Tendler | Director, General Counsel and Secretary | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 12 Dec 2025 | 16,850 | 258,795 | - | 0.9 | 15,334 | Common Stock |
| Alignment Healthcare Inc | Dawn Maroney | President | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 12 Dec 2025 | 16,681 | 1,780,556 | - | 20.0 | 333,960 | Common Stock |
| Merus N.V | Mark T. Iwicki | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 16,604 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Maxine Gowen | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 16,604 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Paolo Pucci | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 16,604 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Gregory D. Perry | Chief Financial Officer & PFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 16,604 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Anand Mehra | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 16,604 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Victor Sandor | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 16,604 | 0 | - | - | Share Option (right to buy) | |
| Merus N.V | Len Kanavy | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 16,604 | 0 | - | - | Share Option (right to buy) | |
| First Western Fin Inc | Scott C. Wylie | Director, CHAIRMAN, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 25.00 per share. | 12 Dec 2025 | 16,500 | 772,653 (9%) | 0% | 25 | 412,500 | Common Stock |
| First Western Fin Inc | Scott C. Wylie | Director, CHAIRMAN, CEO AND PRESIDENT | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 16,500 | 0 | - | - | Stock Option Right to Buy | |
| Hyliion Holdings Corporation | Jon T. Panzer | Chief Financial Officer | Other type of transaction at price $ 1.94 per share. | 12 Dec 2025 | 16,440 | 873,350 | - | 1.9 | 31,894 | Common Stock |
| Traws Pharma Inc | Robert R Redfield | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 16,419 | 113,919 (0%) | 0% | 0 | Common Stock | |
| Traws Pharma Inc | Nikolay Savchuk | Director, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 16,419 | 150,606 (0%) | 0% | 0 | Common Stock | |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 92.05 per share. | 12 Dec 2025 | 16,403 | 425,633 | - | 92.0 | 1,509,896 | Common Stock |
| Merus N.V | Sven Ante Lundberg | Director, President, CEO & PEO | 12 Dec 2025 | 16,372 | 0 (0%) | 0% | 97 | 1,588,084 | Common Shares | |
| Traws Pharma Inc | John H. Leaman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2025 | 16,234 | 16,234 | - | - | Stock Option (right to purchase) | |
| First Western Fin Inc | Scott C. Wylie | Director, CHAIRMAN, CEO AND PRESIDENT | Sale of securities on an exchange or to another person at price $ 25.72 per share. | 12 Dec 2025 | 16,171 | 756,482 (9%) | 0% | 25.7 | 415,918 | Common Stock |
| Merus N.V | Harry Shuman | VP Controller, PAO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 16,000 | 0 | - | - | Share Option (right to buy) | |
| Ouster Inc (Class A) | Mark Frichtl | Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 24.98 per share. | 12 Dec 2025 | 15,661 | 652,571 | - | 25.0 | 391,207 | Common Stock |
| Hyliion Holdings Corporation | Cheri Lantz | Chief Strategy Officer | Other type of transaction at price $ 1.94 per share. | 12 Dec 2025 | 15,646 | 746,904 | - | 1.9 | 30,353 | Common Stock |
| Pagaya Tech Ltd (Class A) | Tami Rosen | Director, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 15,625 | 78,125 | - | - | Restricted Stock Unit | |
| Pagaya Tech Ltd (Class A) | Tami Rosen | Director, Chief Development Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 15,625 | 53,169 | - | 0 | Class A Ordinary Share | |
| Catalyst Pharma Inc | Molly Harper | Director | Sale of securities on an exchange or to another person at price $ 23.20 per share. | 12 Dec 2025 | 15,527 | 13,579 (0%) | 0% | 23.2 | 360,195 | Common stock, par value $0.001 per share |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 15,489 | 1,984,511 | - | - | Option (Right to Buy) | |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Sale of securities on an exchange or to another person at price $ 66.24 per share. | 12 Dec 2025 | 15,489 | 0 (0%) | 0% | 66.2 | 1,025,991 | Common Stock |
| Las Vegas Sands | Robert Glen Goldstein | Director, Chairman & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 50.33 per share. | 12 Dec 2025 | 15,489 | 15,489 (0%) | 0% | 50.3 | 779,561 | Common Stock |
| HubSpot Inc | Dharmesh Shah | Director, Chief Technology Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 15,464 | 1,274,680 (2%) | 0% | 0 | Common Stock | |
| Comstock Holding Co. Inc (Class A) | Robert P. Pincus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 15,385 | 59,308 (0%) | 0% | 0 | Class A Common Stock, $0.01 par value | |
| Academy Sports and Outdoors Inc | Brian T. Marley | Director | Sale of securities on an exchange or to another person at price $ 55.24 per share. | 12 Dec 2025 | 15,152 | 44,526 | - | 55.2 | 836,996 | Common Stock |
| CPS Tech Corp | Charles Kellogg Griffith | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.55 per share. | 12 Dec 2025 | 15,000 | 56,792 (0%) | 0% | 1.6 | 23,250 | Common Stock |
| CPS Tech Corp | Charles Kellogg Griffith | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 15,000 | 80,000 | - | - | Common Stock Option | |
| Antero Midstream Corp | Michael N. Kennedy | Director, See Remarks | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 15,000 | 1,349,090 (0%) | 0% | 0 | Common stock, par value $0.01 per share | |
| Amplitech Grp Inc | Andrew Dylan Lee | Director | Grant, award, or other acquisition of securities at price $ 3.08 per share. | 12 Dec 2025 | 15,000 | 60,000 | - | 3.1 | 46,200 | Common Stock |
| Amplitech Grp Inc | Daniel Richard Mazziota | Director | Grant, award, or other acquisition of securities at price $ 3.08 per share. | 12 Dec 2025 | 15,000 | 262,900 | - | 3.1 | 46,200 | Common Stock |
| Amplitech Grp Inc | Shailesh Modi | Director | Grant, award, or other acquisition of securities at price $ 3.08 per share. | 12 Dec 2025 | 15,000 | 15,000 | - | 3.1 | 46,200 | Common Stock |
| Aptargroup Inc | Daniel Ackerman | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 71.12 per share. | 12 Dec 2025 | 15,000 | 44,607 (0%) | 0% | 71.1 | 1,066,800 | Common Stock |
| Aptargroup Inc | Daniel Ackerman | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Dec 2025 | 15,000 | 0 | - | - | Stock Option | |
| Aptargroup Inc | Daniel Ackerman | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 121.23 per share. | 12 Dec 2025 | 15,000 | 29,607 (0%) | 0% | 121.2 | 1,818,435 | Common Stock |
| Xeris Biopharma Holdings Inc | B. J. Bormann | Director | Sale of securities on an exchange or to another person at price $ 7.09 per share. | 12 Dec 2025 | 15,000 | 142,500 (0%) | 0% | 7.1 | 106,415 | Common Stock |
| Datadog Inc (Class A) | Michael Callahan | Director | 12 Dec 2025 | 15,000 | 27,496 (0%) | 0% | 0 | Class A Common Stock | ||
| Datadog Inc (Class A) | Michael Callahan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Dec 2025 | 15,000 | 12,496 (0%) | 0% | 0 | Class A Common Stock | |
| Datadog Inc (Class A) | Michael Callahan | Director | 12 Dec 2025 | 15,000 | 240,542 | - | - | Class B Common Stock | ||
| Rocket Lab USA Inc | Merline Saintil | Director | Sale of securities on an exchange or to another person at price $ 65.00 per share. | 12 Dec 2025 | 15,000 | 398,529 | - | 65 | 975,000 | Common Stock |
| Xperi Inc | Rebecca K. Marquez | CLO and Secretary | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.16 per share. | 12 Dec 2025 | 14,943 | 179,629 | - | 6.2 | 92,049 | Common Stock |
| Ultralife Corp | Bradford T. Whitmore | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 5.66 per share. | 12 Dec 2025 | 14,882 | 1,207,043 (7%) | 0% | 5.7 | 84,263 | Common Stock |
| Artiva Biotherapeutics Inc | Heather Raymon | SVP, Research and Development | Sale or transfer of securities back to the company at price $ 0.00 per share. | 12 Dec 2025 | 14,819 | 0 | - | - | Employee Stock Option (Right to Buy) | |
| Disc Medicine Inc | Kevin Bitterman | Director | Sale of securities on an exchange or to another person at price $ 91.18 per share. | 12 Dec 2025 | 14,811 | 358,413 | - | 91.2 | 1,350,467 | Common Stock |
| Apple Hospitality REIT Inc | Nelson G. Knight | President Real Estate & Invest | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.12 per share. | 12 Dec 2025 | 14,792 | 933,289 (0%) | 0% | 12.1 | 179,279 | Common Shares |
| Apple Hospitality REIT Inc | Elizabeth S. Perkins | SVP & Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.12 per share. | 12 Dec 2025 | 14,650 | 347,994 (0%) | 0% | 12.1 | 177,558 | Common Shares |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.